EUVIMEDOpdag EUVIMED
Open access

Cohesin and NuRD antagonistically drive alternative neuronal fates via PLZF transcription factors

Dongyeop Lee iD, Takashi Hirose, H Robert Horvitz iD

Science Advances · 2026-07-31 · 12 (31)

DOI: 10.1126/sciadv.aec9329 ↗

At a glance

Journal article in Science Advances, published on 2026-07-31. Written by Dongyeop Lee and 2 co-authors. Institution: Howard Hughes Medical Institute, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Major MEDLINE topics: Chromosomal Proteins, Non-Histone, Cell Cycle Proteins, Mi-2 Nucleosome Remodeling and Deacetylase Complex, Neurons. 95 references. The full text is freely available in PubMed Central. Funded by: NCI NIH HHS, NIH HHS, NIGMS NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Diverse genetic and epigenetic factors cooperate to specify cellular fates during development. Establishing these fates is especially critical in the nervous system, which comprises diverse neuronal cell types. How genomic architecture interfaces with epigenetic regulators to drive transcriptional programs underlying neuronal fates remains poorly understood. Here, we show that cohesin, a protein complex that shapes genomic architecture, promotes GABAergic fate specification in a subset of neurons in the nematode Caenorhabditis elegans . This process is facilitated by EOR-1, a homolog of the human promyelocytic leukemia zinc finger (PLZF) transcription factor. The nucleosome remodeling and deacetylase (NuRD) complex and TRA-4, another PLZF homolog, promote tyraminergic fate in the normally GABAergic neurons when cohesin or EOR-1 function is lost, revealing an antagonistic mechanism determining alternative neuronal fates. These findings highlight a critical interplay among genome architecture, epigenetic remodeling, and transcriptional regulation in neuronal fate specification and, given the evolutionary conservation of these factors, suggest a mechanism underlying neural development across species.

Subjects

MeSH terms (MEDLINE)

Chromosomal Proteins, Non-HistoneCell Cycle ProteinsMi-2 Nucleosome Remodeling and Deacetylase ComplexNeuronsCaenorhabditis elegans ProteinsPromyelocytic Leukemia Zinc Finger ProteinTranscription FactorsAnimalsCohesinsCaenorhabditis elegansEpigenesis, GeneticCell DifferentiationGene Expression Regulation, DevelopmentalGABAergic Neurons

Substances

Chromosomal Proteins, Non-HistoneCohesinsCell Cycle ProteinsMi-2 Nucleosome Remodeling and Deacetylase ComplexCaenorhabditis elegans ProteinsPromyelocytic Leukemia Zinc Finger ProteinTranscription Factors

Authors and institutions

  • Howard Hughes Medical Institute, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

ORCID profiles: Dongyeop Lee, H Robert Horvitz

Funding

  • NCI NIH HHS
  • NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health
  • Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
  • Office of Infrastructure
  • Postdoctoral Fellowship Program of the National Research Foundation of Korea

Cite

APA

Lee, D., Hirose, T., & Horvitz, H. R. (2026). Cohesin and NuRD antagonistically drive alternative neuronal fates via PLZF transcription factors. Science Advances, 12(31). https://doi.org/10.1126/sciadv.aec9329

Vancouver

Lee D, Hirose T, Horvitz HR. Cohesin and NuRD antagonistically drive alternative neuronal fates via PLZF transcription factors. Science Advances. 2026;12(31). doi:10.1126/sciadv.aec9329

BibTeX
@article{Lee2026,
  author = {Lee, Dongyeop and Hirose, Takashi and Horvitz, H Robert},
  title = {Cohesin and NuRD antagonistically drive alternative neuronal fates via PLZF transcription factors},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {31},
  doi = {10.1126/sciadv.aec9329}
}
Start for free →